Risk assessment and thromboprophylaxis for venous thromboembolism in the puerperium in a tertiary health facility in Nigeria

Authors

  • Mkpe Abbey Department of Obstetrics and Gynaecology, Rivers State University Teaching Hospital, Port Harcourt, Rivers State, Nigeria
  • Kinikanwo I. Green Department of Obstetrics and Gynaecology, University of Port Harcourt Teaching Hospital, Port Harcourt Rivers State, Nigeria
  • Roseline Iheagwam Department of Obstetrics and Gynaecology, Rivers State University Teaching Hospital, Port Harcourt, Rivers State, Nigeria
  • Chris Akani Department of Obstetrics and Gynaecology, University of Port Harcourt Teaching Hospital, Port Harcourt Rivers State, Nigeria

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20214626

Keywords:

Risk assessment, Thromboprophylaxis, Venous thromboembolism, puerperium, Tertiary health facility

Abstract

Background: Venous thromboembolism (VTE) is a leading cause of maternal morbidity and mortality in the puerperium. Unfortunately in Nigerian tertiary institutions, there is paucity of information about its risk factors, screening for it, and its prophylaxis. The aim of the study therefore was to review the VTE risk and thromboprophylaxis in the puerperium at the University of Port Harcourt Teaching Hospital (UPTH), Nigeria.

Methods: A retrospective cross-sectional study carried out at the University of Port Harcourt Teaching Hospital (UPTH). The following data were extracted from the notes of 424 consecutive inpatients postnatal women who delivered from the 1st of January to the 30th of April 2020: history/demographic characteristics, risk factors for VTE using the RCOG Green top guideline No. 37a.of 2015 as a benchmark, thromboprophylaxis, diagnosis and treatment of VTE. Women with a VTE event in the preceding 4 months before pregnancy were excluded. Data was analysed using a statistical package for social science (SPSS) software, version 18.

Results: Risk assessment for VTE and its prophylaxis in the puerperium were not routine practice at the UPTH. 420 (99.06%) out of the total 424 postpartum women that were assessed were at significant risk of developing VTE and therefore needed to be on thromboprophylaxis with low molecular weight heparin. Irrespective of the high prevalence of risk factors and the fact that 100 (23.58%) of the patients had symptoms and signs of VTE, no case of VTE was recorded in the study population. Paucity of information and lack of knowledge about the diseases may be responsible for that.

Conclusions: 420 (99.06%) out of the total 424 puerperal women were at significant risk of developing VTE and therefore needed to be on thromboprophylaxis in the puerperium. It was therefore recommended that a national guideline on VTE in the puerperium be written, taking into consideration local disease topography, ethnic diversity and the level of economic development in Nigeria.

References

Kuriya A, Piedimonte S, Spence AR, Czuzoj-Shulman N, Kezouh A, Abenhaim HA. Incidence and causes of maternal mortality in the USA. J Obstet Gynaecol Res. 2016;42(06):661-8.

Knight M, Kenyon S, Brocklehurst P, Neilson J, Shakespeare J, Kurinczuk JJ. Saving Lives, Improving Mothers’ Care: Lessons learned to inform future maternity care from the UK and Ireland. Confidential Enquiries into Maternal Deaths and Morbidity 2009–2012. Oxford, UK: University of Oxford. 2014.

Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143:697-706.

Sultan AA, West J, Tata LJ, Fleming KM, Nelson-Piercy C, Grainge MJ. Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study. Br J Haematol. 2012;156:366-73.

Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6:632-7.

Jackson E, Curtis KM, Gaffield ME. Risk of venous thromboembolism during the postpartum period: a systematic review. Obstet Gynecol. 2011;117:691-703.

Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case– control study. J Thromb Haemost. 2008;6:905-12.

Lindqvist P, Dahlbäck B, MarŜál K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 1999; 94:595-9.

Kane EV, Calderwood C, Dobbie R, Morris C, Roman E, Greer IA. A population-based study of venous thrombosis in pregnancy in Scotland 1980–2005. Eur J Obstet Gynecol Reprod Biol. 2013;169:223-9.

Liu S, Rouleau J, Joseph KS, Sauve R, Liston RM, Young D, et al. Maternal Health Study Group of the Canadian Perinatal Surveillance System. Epidemiology of pregnancy-associated venous thromboembolism: a population-based study in Canada. J Obstet Gynaecol Can. 2009;31:611-20.

Virkus RA, Løkkegaard EC, Bergholt T, Mogensen U, LanghoffRoos J, Lidegaard Ø. Venous thromboembolism in pregnant and puerperal women in Denmark 1995–2005. A national cohort study. Thromb Haemost. 2011;106:304-9.

Kamdem F, Ngahane BHM, Hamadou B, Mongyui A, Doualla MS, Jingi AM, et al. Epidemiology, Clinical Presentations and In-Hospital Mortality of Venous Thromboembolism at the Douala General Hospital: A Cross-Sectional Study in Cameroon, Sub-Saharan Africa. World J Cardiovasc Dis. 2008;8:123-32.

Korubo KI, O. N. Ekeke ON. Awareness of venous thromboembolism among doctors in a Nigerian tertiary centre. East Afr Med J. 2015;92(12).

Lewis G. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer - 2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH. 2007.

Centre for Maternal and Child Enquiries (CMACE). Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–08. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011;118:1-203.

Rath W, Tsikouras P, von Tempelhoff GF. Pharmacological Thromboprophylaxis during pregnancy and the puerperium: recommendations from current guidelines and their critical comparison [in German]. Z Geburtshilfe Neonatol. 2016;220(03):95-105.

Gris JC, Aoun J, Rzaguliyeva L, Begum R, Salah H, Tugushi T, et al. Risk Assessment and Management of Venous Thromboembolism in Women during Pregnancy and Puerperium (SAVE): An International, Cross-sectional Study. TH Open. 2018;2(2):116-30.

Al-Sabbak M. RCOG Greentop guideline No. 37a. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Conference: scientific day of obstetric and gynecology. 2015.

Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. World Health Organization. 2001.

Omunakwe HE, Ekeke ON, Korubo KI. Clinicians’ awareness on thromboprophylaxis in cancer-associated thrombosis. Afr J Med Health Sci. 2015;14:135-9.

Downloads

Published

2021-11-25

Issue

Section

Original Research Articles